Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.64368 | 80 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.42449 | 78 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.53838 | 79 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.96842 | 81 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.42297 | 78 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.72564 | 82 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.90873 | 83 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.49063 | 79 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.58102 | 79 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.59268 | 79 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.58599 | 80 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.01066 | 82 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.4366 | 79 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.35627 | 78 |